Your browser doesn't support javascript.
loading
ENTPD1 (CD39) Expression Inhibits UVR-Induced DNA Damage Repair through Purinergic Signaling and Is Associated with Metastasis in Human Cutaneous Squamous Cell Carcinoma.
Whitley, Melodi Javid; Suwanpradid, Jutamas; Lai, Chester; Jiang, Simon W; Cook, Jonathan L; Zelac, Daniel E; Rudolph, Ross; Corcoran, David L; Degan, Simone; Spasojevic, Ivan; Levinson, Howard; Erdmann, Detlev; Reid, Claire; Zhang, Jennifer Y; Robson, Simon C; Healy, Eugene; Havran, Wendy L; MacLeod, Amanda S.
Afiliación
  • Whitley MJ; Department of Duke Dermatology, Duke University School of Medicine, Durham, North Carolina, USA.
  • Suwanpradid J; Department of Duke Dermatology, Duke University School of Medicine, Durham, North Carolina, USA.
  • Lai C; Dermatopharmacology, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom; Department of Dermatology, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.
  • Jiang SW; Department of Duke Dermatology, Duke University School of Medicine, Durham, North Carolina, USA.
  • Cook JL; Department of Duke Dermatology, Duke University School of Medicine, Durham, North Carolina, USA.
  • Zelac DE; Department of Dermatology and Mohs Surgery, Scripps Clinic, La Jolla, California, USA.
  • Rudolph R; Division of Plastic Surgery, Scripps Clinic, San Diego, California, USA; Division of Plastic Surgery, University of California San Diego, San Diego, California, USA.
  • Corcoran DL; Center for Genomic and Computational Biology, Duke University School of Medicine, Durham, North Carolina, USA; Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, North Carolina, USA.
  • Degan S; Department of Duke Dermatology, Duke University School of Medicine, Durham, North Carolina, USA.
  • Spasojevic I; Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA; PK/PD Core Lab, Duke Cancer Institute, Durham, North Carolina, USA.
  • Levinson H; Division of Plastic, Maxillofacial, and Oral Surgery, Duke Department of Surgery, Duke University School of Medicine, Durham, North Carolina, USA.
  • Erdmann D; Division of Plastic, Maxillofacial, and Oral Surgery, Duke Department of Surgery, Duke University School of Medicine, Durham, North Carolina, USA.
  • Reid C; Dermatopharmacology, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom; Department of Dermatology, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.
  • Zhang JY; Department of Duke Dermatology, Duke University School of Medicine, Durham, North Carolina, USA; Pinnell Center for Investigative Dermatology, Department of Duke Dermatology, Duke University School of Medicine, Durham, North Carolina, USA; Duke Cancer Institute, Duke University School of Medicine, D
  • Robson SC; Department of Anesthesia, Beth Israel Deaconess Medical Center, Harvard Medical School, Harvard University, Boston, Massachusetts, USA; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard University, Boston, Massachusetts, USA.
  • Healy E; Dermatopharmacology, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom; Department of Dermatology, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.
  • Havran WL; Department of Immunology and Microbiology, The Scripps Research Institute, San Diego, California, USA.
  • MacLeod AS; Department of Duke Dermatology, Duke University School of Medicine, Durham, North Carolina, USA; Pinnell Center for Investigative Dermatology, Department of Duke Dermatology, Duke University School of Medicine, Durham, North Carolina, USA; Duke Cancer Institute, Duke University School of Medicine, D
J Invest Dermatol ; 141(10): 2509-2520, 2021 10.
Article en En | MEDLINE | ID: mdl-33848530
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Apirasa / Neoplasias Cutáneas / Rayos Ultravioleta / Carcinoma de Células Escamosas / Adenosina / Reparación del ADN Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Apirasa / Neoplasias Cutáneas / Rayos Ultravioleta / Carcinoma de Células Escamosas / Adenosina / Reparación del ADN Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article